Presentation is loading. Please wait.

Presentation is loading. Please wait.

Determination of polycyclic aromatic hydrocarbons and its monohydroxilated metabolites in human liver cells using gas chromatography and high performance.

Similar presentations


Presentation on theme: "Determination of polycyclic aromatic hydrocarbons and its monohydroxilated metabolites in human liver cells using gas chromatography and high performance."— Presentation transcript:

1 Determination of polycyclic aromatic hydrocarbons and its monohydroxilated metabolites in human liver cells using gas chromatography and high performance liquid chromatography with mass spectrometry Vincent Lal PhD candidate 14th April 2017

2 Overview Background Methodology Results and discussion Conclusions
Acknowledgements

3 Over 3 million contaminated sites
world wide Potential risk (human health) Remediation of sites contaminant time cost

4 Australian HRA guidelines
Environmental Health Risk Assessment (EHRA) National Environment Protection Measure (NEPM) Soil based Health Investigation Level (HILs)

5 Real estate issue? Former gasworks site in Sydney, Australia

6 Human health risk assessment
Soil (HIL based on land-use + contaminant) – NEPM Site specific (soil properties) Soil particle size ( < 250 µm)

7 Remediation gasworks site - Toowoomba. Cost: $20,000,000

8 PAHs in gasworks contaminated soil and sediment (Australia and beyond)
Country Matrix Value (mg/kg) Reference Australia Soil 335 – 8645 Thavamani et al. 2011 United States of America Koganti et al. 1998 United Kingdom Sediment 75500 Goodfellow et al. 2001 Khalil et al. 2006 Kreitinger et al. 2007 France Haeseler et al. 1999 Stroo et al. 2000 2 - 68 Cave et al. 2010 NEPM - Health Investigation Level (HIL A) ΣPAHs (residental) = 300 mg/kg, B[a]P = 3 mg/kg

9 Simulated in vivo conditions
Overall project Compounds TEF* IARC Pyrene 0.001 3 Naphthalene 2B Phenanthrene Benzo[a]pyrene 1.0 1 Pb/Pb(C2H3O2)2·3H2O 2A As/NaAsO2 Cd/CdCl2 Exposure Effects UBM stomach & small intestine Bioaccessibility Extracellular In vitro Cell culture Intracellular Genotoxicity Cytoxicity ROS AhR Uptake Metabolism Bioavailability, Metabolism . Simulated in vivo conditions Inform risk assessor, regulator, land owner

10 Which PAHs? Compound Rings IARC Benzo[a]pyrene 5 1 Pyrene 4 2B
Phenanthrene Naphthalene 3 2

11 Methodology

12 Cell PAH uptake – solution

13

14 Methodology overview (PAHs + OH-PAHs)
PAH dose: 5µM Solution: Pure compound HepG2 (human liver cells)

15

16

17

18

19 Compound (N = 10) Recovery (%) 1 min RSD (%) 2 min Naphthalene 5 Phenanthrene 10 7 Pyrene Benzo[a]pyrene 16 8 1-OH Naphthalene 2-OH Naphthalene 1-OH Phenanthrene 2-OH Phenanthrene 3-OH Phenanthrene 4-OH Phenanthrene 1-OH Pyrene 3-OH Benzo[a]pyrene 20

20 Compound (N = 10) LOD (pg mg-1) Naphthalene 1-OH Naphthalene 2-OH Naphthalene 5 0.1 Phenanthrene 1-OH Phenanthrene 2-OH Phenanthrene 3-OH-Phenanthrene 4-OH Phenanthrene Pyrene 1-OH Pyrene Benzo[a]pyrene 3-OH Benzo[a]pyrene 10

21 Results and discussion

22 Uptake – conc dependent (p < 0.05 )
- instantaneous indicating passive diffusion - Maximum 3 – 6 h plateau up to 24 h - Phase 1 metabolite 3-OH B[a]P, indicating metabolic activation - Continued to increase over exposure period

23

24 Key findings This is the first application of using a QuEChERS approach with an in vitro analysis using the HepG2 cells (biological matrix) Modified QuEChERs procedure is adaptable, simple and is efficient in the assessment of PAHs and OH-PAHs in small amount of biological samples, useful in risk assessment studies Spike recovery experiment indicated method was sufficient to test for major metabolites of PAHs

25 Uptake of PAHs into HepG2 cells was significantly influenced in a
concentration dependent manner Almost instantaneous uptake of PAHs – passive diffusion Metabolic capacity of HepG2 resulted in formation of major metabolites that can be quantified and be useful biomarkers in vitro studies

26 Acknowledgement Principal supervisor: Prof. Jack Ng.
The University of Queensland, National Research Centre for Environmental Toxicology (EnTox), 39 Kessels Road, Coopers Plains, Brisbane, Australia. Associate supervisor: Dr. Cheng Peng Toxicology (EnTox), 39 Kessels Road, Coopers Plains, Brisbane, Australia. Associate supervisor: Dr. Mary Fletcher The University of Queensland, Queensland Alliance for Agriculture and Food Innovation (QAAFI), 39 Kessels Road, Coopers Plains, Brisbane, Australia. Associate supervisor: Dr. Stephen Were Department of Agriculture and Fisheries (DAF), Biosecurity Queensland, 39 Kessels Road, Coopers Plains, Brisbane, Australia.

27 Other colleagues and advisors
Dr. Sasikumar Muthusamy Dr. Qing (Summer) Xia Patrick Segel, Dr. Ken Tong and DAF team Eugene inorganics QHFSS QAEHS staff and students Prof. Jochen Muller (UQ) and Prof. Trevor Penning Groups (Upen)

28 Funding for this project is provided by CRC CARE
Project number: Publications – Environ. Techol Innovation 2015 Mutagenesis Chemosphere UQ – UQI Scholarship and CRC CARE Scholarship UQ GSITA Scholarship Australian Govt. Greg Urwin Award

29 Thank you…


Download ppt "Determination of polycyclic aromatic hydrocarbons and its monohydroxilated metabolites in human liver cells using gas chromatography and high performance."

Similar presentations


Ads by Google